SPATA5: A Drug Target / Disease Biomarker (G166378)

Target Name: SPATA5

NCBI ID: G166378

SPATA5

SPATA5: A Drug Target / Disease Biomarker

SPATA5 is a gene that has been identified as a potential drug target or biomarker for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

The SPATA5 gene is a non-coding RNA molecule that is expressed in various tissues and cells throughout the body. It is a part of a larger gene family that is known as the SPATA gene family, which is characterized by a specific transcription factor that has been shown to play a role in the regulation of gene expression.

SPATA5 has been shown to be involved in the regulation of various cellular processes that are important for the development and progression of many diseases. For example, SPATA5 has been shown to be involved in the regulation of cell proliferation, differentiation, and survival, as well as in the regulation of cell-cell adhesion and migration.

In addition to its role in cellular processes, SPATA5 has also been shown to be involved in the regulation of cellular signaling pathways that are important for the development and progression of many diseases. For example, SPATA5 has been shown to be involved in the regulation of the PI3K/Akt signaling pathway, which is a well-established signaling pathway that is involved in the regulation of cellular processes that are important for the development and progression of many diseases, including cancer.

SPATA5 has also been shown to be involved in the regulation of inflammation, which is a critical aspect of the development and progression of many diseases. For example, SPATA5 has been shown to be involved in the regulation of the production and function of immune cells, which are important for the regulation of inflammation.

In conclusion, SPATA5 is a gene that has been shown to be involved in a wide range of cellular processes that are important for the development and progression of many diseases. As such, it is a promising candidate for drug targeting or biomarker analysis. Further research is needed to fully understand the role of SPATA5 in the regulation of cellular processes and the development and progression of diseases.

Protein Name: Spermatogenesis Associated 5

Functions: ATP-dependent chaperone, which plays an essential role in the cytoplasmic maturation steps of pre-60S ribosomal particles by promoting the release of shuttling protein RSL24D1/RLP24 from the pre-ribosomal particles (PubMed:35354024). Acts together with SPATA5L1, C1orf109 and CINP (PubMed:35354024). May be involved in morphological and functional mitochondrial transformations during spermatogenesis (By similarity)

The "SPATA5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SPATA5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets